Generation Bio (GBIO)
(Delayed Data from NSDQ)
$2.44 USD
+0.10 (4.27%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $2.43 -0.01 (-0.41%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for Generation Bio Co falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -126.61 | -136.64 | -119.15 | -80.52 | -61.32 |
Depreciation/Amortization & Depletion | 5.26 | 5.13 | 4.53 | 3.43 | 1.86 |
Net Change from Assets/Liabilities | 53.54 | 1.05 | 4.18 | -1.71 | 15.23 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 15.07 | 28.02 | 18.62 | 8.66 | 3.88 |
Net Cash From Operating Activities | -52.75 | -102.45 | -91.82 | -70.14 | -40.35 |
Property & Equipment | -7.40 | -8.80 | -5.85 | -5.52 | -19.91 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -2.30 | -183.71 | 198.90 | -199.68 | 67.89 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -9.70 | -192.52 | 193.05 | -205.20 | 47.99 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 36.55 | 13.62 | 215.63 | 326.32 | 0.10 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.73 | -0.63 | -0.96 | -3.23 | -0.02 |
Net Cash from Financing Activities | 35.82 | 12.99 | 214.67 | 323.10 | 0.08 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -26.63 | -281.97 | 315.90 | 47.76 | 7.72 |
Cash at Beginning of Period | 98.86 | 380.84 | 64.94 | 17.18 | 9.47 |
Cash at End of Period | 72.24 | 98.86 | 380.84 | 64.94 | 17.18 |
Diluted Net EPS | -1.96 | -2.35 | -2.12 | -2.95 | NA |
Fiscal Year End for Generation Bio Co falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -74.54 | -126.61 | -91.43 | -63.16 | -32.09 |
Depreciation/Amortization & Depletion | 1.31 | 5.26 | 3.94 | 2.65 | 1.33 |
Net Change from Assets/Liabilities | -17.06 | 53.54 | 48.10 | 49.53 | -1.10 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 58.60 | 15.07 | 11.62 | 8.11 | 4.19 |
Net Cash From Operating Activities | -31.70 | -52.75 | -27.77 | -2.87 | -27.68 |
Property & Equipment | -1.92 | -7.40 | -2.82 | -2.21 | -0.76 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 1.36 | -2.30 | -4.97 | 21.01 | -4.86 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.55 | -9.70 | -7.78 | 18.80 | -5.62 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 36.55 | 36.37 | 36.37 | 36.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.13 | -0.73 | -0.63 | -0.50 | -0.23 |
Net Cash from Financing Activities | -0.13 | 35.82 | 35.74 | 35.87 | 35.77 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -32.38 | -26.63 | 0.19 | 51.80 | 2.48 |
Cash at Beginning of Period | 72.24 | 98.86 | 98.86 | 98.86 | 98.86 |
Cash at End of Period | 39.86 | 72.24 | 99.05 | 150.66 | 101.34 |
Diluted Net EPS | -1.12 | -0.53 | -0.43 | -0.47 | -0.53 |